James Brumley

James Brumley

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He’s now primarily a freelance writer, tapping more than a decade’s worth of broad experience to help investors get more out of the market.

With a background in technical analysis as well as fundamental analysis, James writes with a multifaceted philosophy that combines the importance of company performance with the power of stock-trade timing. His commentary is as apt to focus on a chart as it is earnings, as he believes this dual approach is the only way an investor has a shot at consistently beating the market.

James’ work has appeared at several websites, including Street Authority, Motley Fool, Kapitall and Investopedia. When not writing as a journalist, James works on his book explaining his multipronged approach to investing.

Recent Articles

Search Stocks Are Soaring, Set to Keep Going

Internet names like Google and Qihoo have been outperforming the market lately ... and, believe it or not, their climbs upward should continue. Here's why.

BHP Might Be a Mess, But It’s a ‘Buy,’ Too

BHP Billiton's potential isn't for the prettiest reasons -- low iron and coal prices are near a floor and the company is cutting capex -- but it's potential nonetheless.

Gold Bulls Need a Reality Check

Gold is trapped under several rocks as governmental buying pressure wanes, inflation refuses to materialize and the U.S. dollar lays on the accelerator.

Which Stagnant Tech Stock Will Shake Its Funk: Apple, IBM or Amazon?

The market has rallied since November lows, but Apple, Amazon and IBM have been lagging behind. Which of these tech titans will turn around first?

Molycorp’s Pop Isn’t a Sign of Hope — It’s an Escape Hatch

The rare-earth metals stock's pleasantly surprising quarterly figures and subsequent stock pop mask a host of longer-term liabilities that likely will bite MCP shares in the rear.

Mark Zuckerberg: The Quickest of Studies

Facebook's Mark Zuckerberg has passed his trial by fire, transforming from a naive programmer to a savvy, calculated CEO during a year of publicly traded life.

Big Banks Are Taking Issue With Walmart? Cry Me a River

Big banks say that Walmart's financial services should be subject to regulation to protect consumers. What they're really concerned about is an opportunity they already passed on.

The One Thing You Can’t Ignore About Apple

When it comes to Apple, the best advice is simple: Don't both worrying about any of the things that usually matter. It's traded on sentiment, not fundamentals.

Belviq Is Not the Next Fen-Phen … Probably

Arena Pharmaceuticals' withdrawal of its European application for Belviq has turned the stock into a three-ring circus. Don't panic -- just get the facts straight.

3 Things Sears’ Eddie Lampert Doesn’t Get About Retail

Lampert may not be leading Sears down the same dead-end path Ron Johnson took JCPenney, but he should still reconsider these dangerous assumptions.